ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals Inc (QB) (ELTP)

0.742
0.00
(0.00%)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.742
Bid
0.7253
Ask
0.7445
Volume
-
0.00 Day's Range 0.00
0.1626 52 Week Range 0.8194
Market Cap
Previous Close
0.742
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,353,948
Shares Outstanding
1,068,273,108
Dividend Yield
-
PE Ratio
39.36
Earnings Per Share (EPS)
0.02
Revenue
56.63M
Net Profit
20.11M

About Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma... Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Carson City, Nevada, USA
Founded
-
Elite Pharmaceuticals Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ELTP. The last closing price for Elite Pharmaceuticals (QB) was $0.74. Over the last year, Elite Pharmaceuticals (QB) shares have traded in a share price range of $ 0.1626 to $ 0.8194.

Elite Pharmaceuticals (QB) currently has 1,068,273,108 shares outstanding. The market capitalization of Elite Pharmaceuticals (QB) is $792.66 million. Elite Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of 39.36.

ELTP Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0324.507042253520.710.81940.650147180140.72221188CS
40.20738.6915887850.5350.81940.517422708990.68089218CS
120.289563.97790055250.45250.81940.2713539480.55655599CS
260.19736.14678899080.5450.81940.2711546240.53349123CS
520.5731339.3132030790.16890.81940.162617523490.47095299CS
1560.693451428.321318230.048550.81940.026810801210.30256272CS
2600.653733.7078651690.0890.81940.02310062510.21350451CS

ELTP - Frequently Asked Questions (FAQ)

What is the current Elite Pharmaceuticals (QB) share price?
The current share price of Elite Pharmaceuticals (QB) is $ 0.742
How many Elite Pharmaceuticals (QB) shares are in issue?
Elite Pharmaceuticals (QB) has 1,068,273,108 shares in issue
What is the market cap of Elite Pharmaceuticals (QB)?
The market capitalisation of Elite Pharmaceuticals (QB) is USD 792.66M
What is the 1 year trading range for Elite Pharmaceuticals (QB) share price?
Elite Pharmaceuticals (QB) has traded in the range of $ 0.1626 to $ 0.8194 during the past year
What is the PE ratio of Elite Pharmaceuticals (QB)?
The price to earnings ratio of Elite Pharmaceuticals (QB) is 39.36
What is the cash to sales ratio of Elite Pharmaceuticals (QB)?
The cash to sales ratio of Elite Pharmaceuticals (QB) is 13.96
What is the reporting currency for Elite Pharmaceuticals (QB)?
Elite Pharmaceuticals (QB) reports financial results in USD
What is the latest annual turnover for Elite Pharmaceuticals (QB)?
The latest annual turnover of Elite Pharmaceuticals (QB) is USD 56.63M
What is the latest annual profit for Elite Pharmaceuticals (QB)?
The latest annual profit of Elite Pharmaceuticals (QB) is USD 20.11M
What is the registered address of Elite Pharmaceuticals (QB)?
The registered address for Elite Pharmaceuticals (QB) is 321 W. WINNIE LANE, #104, CARSON CITY, NEVADA, 89703
What is the Elite Pharmaceuticals (QB) website address?
The website address for Elite Pharmaceuticals (QB) is www.elitepharma.com
Which industry sector does Elite Pharmaceuticals (QB) operate in?
Elite Pharmaceuticals (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AACAFAAC Technologies Holdings Inc (PK)
$ 4.53
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.0263
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0317
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AACAFAAC Technologies Holdings Inc (PK)
$ 4.53
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.0263
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0317
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
ARCNFArcane Crypto AB (CE)
$ 0.0001
(0.00%)
7.47M
DTREFDateline Resources Ltd (QB)
$ 0.0538
(0.00%)
1.2M
DPLSDarkPulse Inc (PK)
$ 0.0003
(0.00%)
1M
LAEKFLaekna Inc (PK)
$ 7.30
(0.00%)
900k
SMSPFPT Selamat Sempurna TBK (PK)
$ 0.00
(0.00%)
697.9k

ELTP Discussion

View Posts
rocioyogi rocioyogi 36 minutes ago
$33,200,000 is my guess for the fourth quarter's revenues!!!!!  😎 
๐Ÿ‘๏ธ0
Julesb Julesb 43 minutes ago
If no boxes are checked on a Form 8-K regarding earnings, it typically means the company is not reporting a restatement of previously issued financial statements or a clawback of previously awarded compensation based on those restated financials. Form 8-K is used to report significant events, and certain check boxes on the cover page indicate if the filing includes a restatement and/or clawback related to earnings. If these boxes are not checked, the 8-K likely covers other reportable events, such as changes in executive leadership or material agreements
👍️ 1 🪂 1
$7.00 or Nothing $7.00 or Nothing 1 hour ago
Fake king quiet by 7:30 am.

I am worried man. How is your heart today?
๐Ÿ‘๏ธ0
sharkey1 sharkey1 1 hour ago
So whatโ€™s up with this new 8k,
are they trying to say if the boxes sre not checked itโ€™s business as usual

https://ih.advfn.com/stock-market/USOTC/elite-pharmaceuticals-qb-ELTP/stock-news/96286996/form-8-k-current-report
💥 1
sharkey1 sharkey1 1 hour ago
WOW Rocki. Won that one, what a surprise,
Iโ€™ll take it.

CANT WAIT
👍️ 1
jour_trader jour_trader 1 hour ago
Northvale, Northvale, New Jersey--(Newsfile Corp. - June 23, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced today that it would release its 2025 year-end financial results on Monday, June 30, 2025. Elite's management will host a live conference call on Tuesday, July 1, at 11:30 AM EDT to discuss the company's financial and operating results and provide a general business update. Stockholders should submit questions to the company before the call.
🎰 1 👍️ 4
ubueltp ubueltp 1 hour ago
Itโ€™s crazy Henry that you have been sooo wrong for soo long that you are still here and havenโ€™t changed your handle. Wow, very embarrassing
👍️ 1
jour_trader jour_trader 1 hour ago
CC next Tuesday. Email fired off. Earnings release on Monday. 
👍️ 1
HenryB3 HenryB3 1 hour ago
Kool aide is having a new fruity raspberry flavor. Don't drink it, needs a ton of sugar. Sub 12 will be here. No buyout. Kick the can down the road for more dream otc world talk. Here's all you need to know. Don't be exit liquidity.
https://www.reddit.com/r/wallstreetbets/comments/1l7a5hj/my_1_million_investment_triple_up_is_about_to/
๐Ÿ‘๏ธ0
ubueltp ubueltp 2 hours ago
29,777,777.00
๐Ÿ‘๏ธ0
Rj70 Rj70 2 hours ago
$32,750,000
👍️ 1
Bngo Bngo 3 hours ago
The patent for Eliquis (apixaban) is set to expire on 11/21/26 . This means that generic versions of the drug may become available after this date.  

The main Xarelto (rivaroxaban) patent, including pediatric exclusivity, is scheduled to expire in May 2025. Specifically, one patent expired on February 19, 2025, according to https://www.pharmacytimes.com/view/a-pharmacist-s-guide-to-blockbuster-patent-expirations-2025-and-beyond.%C2%A0This
This patent covers the solid oral formulation of the drug. Other patents protecting specific dosage or combination regimens may extend beyond this date, potentially until 2034 or 2039. 
How many of these other blockbuster expiring drugs will be in Elite's future pipeline?
Future Rocket Fuel !!! 
A Pharmacist's Guide to Blockbuster Patent Expirations: 2025 and Beyond

https://www.pharmacytimes.com/view/a-pharmacist-s-guide-to-blockbuster-patent-expirations-2025-and-beyond


Top 10 Blockbuster Drug Patents Expiring in 2025

https://pharsight.greyb.com/articles/top-10-blockbuster-drugs-expiring-in-2025
👍️ 6 🧐 1
Bngo Bngo 3 hours ago
The patent for Eliquis (apixaban) is set to expire on . This means that generic versions of the drug may become available after this date. 

The main Xarelto (rivaroxaban) patent, including pediatric exclusivity, is scheduled to expire in . Specifically, one patent expired on February 19, 2025, https://www.pharmacytimes.com/view/a-pharmacist-s-guide-to-blockbuster-patent-expirations-2025-and-beyond. This patent covers the solid oral formulation of the drug. Other patents protecting specific dosage or combination regimens may extend beyond this date, potentially until 2034 or 2039. 
Rocket fuel !!!

https://www.pharmacytimes.com/view/a-pharmacist-s-guide-to-blockbuster-patent-expirations-2025-and-beyond


https://pharsight.greyb.com/articles/top-10-blockbuster-drugs-expiring-in-2025
👍️ 5 😎 1
Jimmy Joe Jimmy Joe 5 hours ago
You should know by now Naz is about no hype. He under promises and over delivers always.!!!!!

Pretty much. How was this ticker manipulated and held at $0.02-$0.03 when the Company was cash flow positive~? For years~? Revenues growing each Q~?

And the needle movers have moved the needle......... BUT AGAIN MMs gonna manipulate the ticker price DOWN.
Why~? Why are they so desperate to hold Elite down~? I know why.
Should be trading much higher even now WITHOUT A BUYOUT PRICE as the booster seat child. And it isn't the OTC holding it down either.

Nobody can stop us. SequestOx is coming to the market."

2017 - "We will be on the Nasdaq within a couple of years and we will be in dollarland around that time within a couple of years."

So back in 2014 when NH made that statement, "nobody can stop us........" the Sacklers and Purdue stopped Elite from bringing their formulation to market even though OxyContin was not abuse proof by any stretch of the imagination. The formulation had a few flaws where its abuse prevention could easily be defeated.
Think the FDA wasn't bought off by billionaires~? Think again. Even had a poster who was supposedly an MD come on this board and claim SequestOx was Zombie SequestOx, Total bullshit~~! All in MY opinion of course.

Bioequivalence studies went well for SequestOx, but the FDA always pressed for Elite to jump through one more hoop. Always the one more hoop to jump through. And then the FDA basically said sorry no more hoops left.
Obviously this was a political move on behalf of Purdue and the Sackler family in my opinion. $Billions were made off of this flawed formulation. Hell, Purdue even had their legal on here defending OxyContin..... aka Dr Lowonbrains.

If it were up to you dude, NH would have been OUT as CEO and Elite would have gone under. But that was the objective all along wasn't it~? Too bad it failed.
NH is just a little smarter than people like you.
To spoof or not to spoof..........that is the question.

And take off that stupid EFFin RED HAT that makes you look like an old dufus. The hat is not needed, you're already there.

Elite baby~!
🌈 1 👍️ 6 💯 3 🤑 1
ThePoorTeacher ThePoorTeacher 6 hours ago
Here we go!! my guess is 34,971,411
👍️ 1
ubueltp ubueltp 12 hours ago
I hope he/she is, good move for someone
๐Ÿ‘๏ธ0
jimr1717 jimr1717 12 hours ago
Dumping more Monday?
๐Ÿ‘๏ธ0
$2.00 or no deal $2.00 or no deal 14 hours ago
LMAO.

- "Nobody can stop us. SequestOx is coming to the market."

2017 - "We will be on the Nasdaq within a couple of years and we will be in dollarland around that time within a couple of years."

You should know by now Naz is about no hype. He under promises and over delivers always.!!!!!
⛔️ 1
$2.00 or no deal $2.00 or no deal 14 hours ago
We LITERALLY will be back in the .80's BEFORE the 10-K is even filed on June 30.

We all know the 4th quarter will be great but in order for this this stock to be back in the 80s cents range we need spectacular.
๐Ÿ‘๏ธ0
NASDAQ2020 NASDAQ2020 14 hours ago
Nasrat building a 🌉 over 🍷to DollarLand !!

Having Henry here is better than going to Rodman Renshaw,

https://rodm.com/
👍️ 3 😎 1
$7.00 or Nothing $7.00 or Nothing 15 hours ago
No worries. Your predictions never pan out lol


โ€”โ€”โ€”โ€”
Very good chance I'm going to have a heart attack at least once during the next 2 weeks:

June 23-27: Possible news each day + possible high volume due to upcoming 10-K and CC
June 30: Actual day of 10-K filing
July 1: Conference call
July 2-3: PPS reaction to conference call
๐Ÿ‘๏ธ0
Maxthedog Maxthedog 16 hours ago
We all know the 4th quarter will be great but in order for this this stock to be back in the 80s cents range we need spectacular. I think for the past 2 quarters after the CC, we headed down and I don't see any reasons to have another situation similar to the other two. Way too much hype again and again and again. You're not getting my 2 cents about the revenues and earnings, been disappointment too many of times.
The kool-aid and bridges are too stupid to comprehend, but this euphoria is also too much. The stock will do fine, just give it time.
BTW, I wish it would zoom up to a buck so it can settle the dollarland.
👍 1
rocioyogi rocioyogi 17 hours ago
You should know by now Naz is about no hype. He under promises and over delivers always.!!!!!
👍 7 💯 1
Jimmy Joe Jimmy Joe 17 hours ago
Very good chance I'm going to have a heart attack at least once during the next 2 weeks:

June 23-27: Possible news each day + possible high volume due to upcoming 10-K and CC
June 30: Actual day of 10-K filing
July 1: Conference call
July 2-3: PPS reaction to conference call

Please please do dude. Nothin' could be finer.

$ELTP baby~!
👍 3 😢 2 🤣 1
mrwrn2010 mrwrn2010 18 hours ago
Break the rules, live a little.

Wouldn't surprise me if the war impacted Dexcel launch but I am hoping for Methadone launch this week.
👍️ 4 😉 1
$2.00 or no deal $2.00 or no deal 19 hours ago
It's not Monday yet.

Thanks.
🤪 1 ☢️ 2 ☣️ 1
mrwrn2010 mrwrn2010 19 hours ago
What's your guess on revenues for Q4?
👍️ 2 🤎 1
IB_ IB_ 19 hours ago
That is the last thing anyone wants to hear !!!!! 😕

This board would be NOTHING without The King of the DD โ€ฆโ€ฆโ€ฆโ€ฆ

Take care of yourself 👑,

IB_🤴
👍️ 1 🚳 1 🤴 1 ⚠️ 1
HenryB3 HenryB3 19 hours ago
kool aide is turning. exit liquidity, here's all you need to know. The narrative is changing. No buyout, No merger. Now its every generic drug market share. The story changes to kick the can down down the road.
https://www.reddit.com/r/wallstreetbets/comments/1l7a5hj/my_1_million_investment_triple_up_is_about_to/
👍️ 1 🗑️ 2 🤣 1 🩳 1 🪠 1
$2.00 or no deal $2.00 or no deal 20 hours ago
Looking forward to it!

As a reminder, the Revenue Guessing Game, which I invented, begins THIS Monday, June 23.
👍️ 2
$2.00 or no deal $2.00 or no deal 20 hours ago
THIS WEEK.

NEXT WEEK:

✅️ Methadone launch

and/or

✅️ Adderall Israel launch
👍️ 2
$2.00 or no deal $2.00 or no deal 20 hours ago
June 30 is the 10-K.

July 1 is the CC.

We should probably have a PR tomorrow morning on the following weeks July 1 or 2nd release of figures and Conf Call date and time 😎
๐Ÿ‘๏ธ0
$2.00 or no deal $2.00 or no deal 20 hours ago
Possible heart attack like me?

Next week will be a nail biter, for sure.
๐Ÿ‘๏ธ0
sharkey1 sharkey1 20 hours ago
I do hope the put a little SPIN in the press release instead of the
same ole copy/paste
👍️ 1
jour_trader jour_trader 20 hours ago
I believe it needs to at least be 3 business days in advance of call. I was thinking Tuesday with questions due Friday. 
๐Ÿ‘๏ธ0
sharkey1 sharkey1 20 hours ago
They always make us wait. Im thinking Thursday.or Friday.
๐Ÿ‘๏ธ0
rocioyogi rocioyogi 21 hours ago
We should probably have a PR tomorrow morning on the following weeks July 1 or 2nd release of figures and Conf Call date and time 😎 
👍️ 1
sharkey1 sharkey1 22 hours ago
OK no. 7, so it looks like they sold every ounce of API they could get their hands on.

GOOD NEWS, The financials next week should be through the roof.
They started in shortage mid April,, and the FDA takes at least a month
To catch up, and report.
So the first three months should be HUGE .
👍️ 5
snupoled snupoled 23 hours ago
Rum,
I wish you well, and cheaper too! but,
blood work is constant hassle!
where as elequis isn"t peeps
want convenience over weekly trips
to blood labs,
best to you!
snup
๐Ÿ‘๏ธ0
snupoled snupoled 23 hours ago
shark!
thanks, great way to start the day, reading about elite pharma
today has the potential to be great!
snup
👍️ 1
$7.00 or Nothing $7.00 or Nothing 23 hours ago
Nasrat was clear during the last cc. They manage the quota carefully so they have enough for the whole year and do not get in stock break.

They also present to the dea the new purchase orders (new clients) every time they go back to the dea for more quota.

This is responsible management.
👍️ 9
sharkey1 sharkey1 24 hours ago
Dr sleep, to me it means they maxed out, for that time period. It says Elites tablets are in
shortage for 3 months, they should get a resupply in July, 3 months is up.
How much they get, is anybodyโ€™s guess, They keep it a secret.
👍️ 2
DrSleep DrSleep 24 hours ago
Does โ€œShortageโ€ mean insufficient API? Or that DEA quota is maxed? Thanks
๐Ÿ‘๏ธ0
rocioyogi rocioyogi 1 day ago
Nice Info thanks here's a real brief clip out of the info you just gave for us but for our potential buyer, it's huge and it will be accomplished. It will come to market within 12 to 18 months for someone huge!!If Elite can navigate these regulatory and legal challenges, the company stands to capitalize on a substantial market opportunity, given the absence of current generic alternatives and the size of the branded drugโ€™s marke
👍️ 3
HenryB3 HenryB3 1 day ago
stop with drinking kool aide. There's no word. Your word was buyout. Not happening! Bridges are being finalized, would you like one?
🩳 1 🪠 1
jour_trader jour_trader 1 day ago
Thx
👍️ 2
JamesF1 JamesF1 1 day ago
Hi again jour_trader, Elite still has 5 out of 7 strengths of Lisdexamfetamine available to order from Cardinal. Adderall IR is doing great. Every strength is available at the moment. Adderall ER on the other hand is completely out of stock at the Cardinal distribution center right now (all strengths). Perhaps an order is coming soon. Things may be completely different at other wholesalers. BTW, what I see at Cardinal does not always match up with the FDA reports.
👍️ 11
NASDAQ2020 NASDAQ2020 1 day ago
https://dps.fda.gov/drugshortages/activeingredient/lisdexamfetamine-dimesylate-capsule

https://dps.fda.gov/drugshortages/activeingredient/amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-saccharate-dextroamphetamine-sulfate-tablet
👍️ 1
NASDAQ2020 NASDAQ2020 1 day ago
https://www.timeanddate.com/countdown/payday?iso=20250630T1615&p0=179&msg=HammerTime+%21%21&font=cursive
👍️ 2
sharkey1 sharkey1 1 day ago
It feels like, most of us here, are in a race to July 1st, will we all get rich
Or will it be WW3, ?

CANT WAIT.

Found a good write up about Elite.

https://www.perplexity.ai/finance/ELTP

Words getting out,
Next week will be a nail biter, for sure.
👍️ 5

Your Recent History

Delayed Upgrade Clock